APA (7th ed.) Citation

AH, B., S, D., M, K., B, L., S, S., E, L., . . . Y, L. (2026). Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease. MedRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.05.29.26354050

Chicago Style (17th ed.) Citation

AH, Beavogui, et al. "Five-year Immunogenicity and Safety Follow-up of the PREVAC Randomized Trial of Vaccines for Zaire Ebola Virus Disease." MedRxiv : The Preprint Server for Health Sciences 2026. https://doi.org/10.64898/2026.05.29.26354050.

MLA (9th ed.) Citation

AH, Beavogui, et al. "Five-year Immunogenicity and Safety Follow-up of the PREVAC Randomized Trial of Vaccines for Zaire Ebola Virus Disease." MedRxiv : The Preprint Server for Health Sciences, 2026, https://doi.org/10.64898/2026.05.29.26354050.